Akums Gets DCGI Approval for Colchicine 0.5 mg Tablets
According to Akums, the approval of Colchicine 0.5 mg Tablets marks a first-time-in-India regulatory milestone for this application.
According to Akums, the approval of Colchicine 0.5 mg Tablets marks a first-time-in-India regulatory milestone for this application.
For people at high risk of a heart attack or stroke, lowering LDL-C with Repatha may not only prevent these events but also reduce the risk of death from cardiovascular disease, according to Amgen.
Philips will collaborate with Johns Hopkins University and Boston University to develop technologies for remote and increasingly automated endovascular procedures.
The acquisition strengthens Medtronic’s neurovascular portfolio by adding Scientia’s advanced access technologies, including guidewires and catheters.